[1] Article Title: Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden
	•	Line(s): 4–5
	•	Section: Title Page
	•	Quote(s): “Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden”

⸻

[2] Publication Year: 2000
	•	Line(s): 13
	•	Section: Title Page
	•	Quote(s): “Neuromuscular Disorders 10 (2000) 1–9”

⸻

[3] Region: Europe
	•	Line(s): 6, 25
	•	Section: Title Page, Introduction
	•	Quote(s): “Department of Paediatrics, Sahlgrenska University Hospital–Östra… Sweden”; “Western Sweden has a homogeneous health care system…”

⸻

[4] Country: Sweden
	•	Line(s): 6, 25
	•	Section: Title Page, Introduction
	•	Quote(s): “Sahlgrenska University Hospital… Sweden”; “Western Sweden has a homogeneous health care system…”

⸻

[5] Coverage Area: Regional
	•	Line(s): 44–46
	•	Section: Methods – Study population
	•	Quote(s): “The geographical area studied was the western Swedish health care region, with the city of Göteborg and the Counties of Halland, Bohuslän, Skaraborg and Älvsborg…”

⸻

[6] Study Design: Retrospective
	•	Line(s): 18–19
	•	Section: Abstract
	•	Quote(s): “A retrospective epidemiological study of neuromuscular disorders was carried out in children…”

⸻

[7] Study Population: Children born between 1979 and 1994 in western Sweden
	•	Line(s): 19, 48
	•	Section: Abstract, Methods – Patients
	•	Quote(s): “…children born between 1979 and 1994 in western Sweden.”; “We intended to identify all individuals with neuromuscular disorders born between 1979 and 1994…”

⸻

[8] Population Characteristics: Children under 16, 20% of Swedish population; 343,941 births
	•	Line(s): 47–51
	•	Section: Methods – Study population
	•	Quote(s): “Children (343,941) (176,787 boys) were born in the study area between 1979 and 1994.”

⸻

[9] Data Source Type: Clinical data, registries, and hospital records
	•	Line(s): 52–63
	•	Section: Methods – Sources used for identification
	•	Quote(s): “Residential and outpatient registers… Muscle biopsy registers… Departments of neurophysiology and clinical genetics…”

⸻

[10] Data Source Details: 12 sources, including hospitals, biopsy labs, and national registry
	•	Line(s): 52–63
	•	Section: Methods – Sources used for identification
	•	Quote(s): “Registers… at the departments of pathology… University of Linköping… National Swedish Board of Health and Welfare’s register of causes of death…”

⸻

[11] Study Timeline Type: Retrospective
	•	Line(s): 18–19
	•	Section: Abstract
	•	Quote(s): “A retrospective epidemiological study…”

⸻

[12] Number of Sites: NR
	•	Line(s): 21, 52
	•	Section: Abstract, Methods – Sources used for identification
	•	Quote(s): “Cases were ascertained from 12 different sources…”; “Residential and outpatient registers… 12 different sources…”

⸻

[13] Study Start Year: 1979
	•	Line(s): 19, 48
	•	Section: Abstract, Methods – Patients
	•	Quote(s): “…children born between 1979 and 1994…”

⸻

[14] Study End Year: 1994
	•	Line(s): 19, 48
	•	Section: Abstract, Methods – Patients
	•	Quote(s): “…children born between 1979 and 1994…”

⸻

[15] Main Ethnicity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[16] Ethnicity Details: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[17] Disease Studied: Neuromuscular disorders, including congenital myasthenic syndrome (CMS)
	•	Line(s): 19–20, Table 1
	•	Section: Abstract, Results – Table 1
	•	Quote(s): “…to determine overall and specific prevalences, overall cumulative incidence and birth incidences of selected disorders…”; “Congenital myasthenic syndrome”

⸻

[18] Diagnosis Method: Clinical features, neurophysiology, biopsy, genetic testing
	•	Line(s): 64–84
	•	Section: Methods – Criteria for inclusion
	•	Quote(s): “…supported by either neurophysiological examinations or an edrophonium test…”; “…clinical diagnosis was supported by electrophysiological or histopathological or molecular genetic investigations…”

⸻

[19] Diagnosis Criteria Details: ENMC criteria and published diagnostic standards
	•	Line(s): 70–72, 84–86
	•	Section: Methods – Criteria for inclusion
	•	Quote(s): “…according to the European Neuromuscular Centre (ENMC) criteria…”; “…criteria described by Tulinius et al.”

⸻

[20] Disease Phase: Both (acute and chronic phases included across diseases)
	•	Line(s): 64–90
	•	Section: Methods – Criteria for inclusion
	•	Quote(s): “…children with neuromuscular symptoms and/or signs on the prevalence day.”; Includes both acute AIDP and chronic CIDP.

⸻

[21] Cohort Age Group: Pediatric
	•	Line(s): 19, 47
	•	Section: Abstract, Methods – Study population
	•	Quote(s): “…in children born between 1979 and 1994…”; “…population <16 years of age…”

⸻

[22] Female % in Cohort: 44%
	•	Line(s): 180
	•	Section: Results – Table 1 (Total cases)
	•	Quote(s): “Total casesa 227 (127/100)” → 127 males, 100 females

⸻

[23] Consanguinity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR